Sol-Gel Technologies (SLGL) Current Assets (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Current Assets of $55.8 million for Q1 2026, up 138.09% year-over-year from $23.4 million in Q1 2025, and up 106.85% quarter-over-quarter from $27.0 million in Q4 2025.

Sol-Gel Technologies (SLGL) Current Assets (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Current Assets data on file, last reported at $55.8 million in Q1 2026.

  • Current Assets for Q1 2026 came in at $55.8 million, up 138.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.8 million (up 138.09% YoY), and the FY2025 annual result was $27.0 million, down 13.82% from the prior year.
  • Current Assets rose to $55.8 million in Q1 2026 per SLGL's latest filing, from $27.0 million in the prior quarter.
  • Over five years, Current Assets peaked at $55.8 million in Q1 2026 and troughed at $23.4 million in Q1 2025.
  • A 5-year average of $40.1 million and a median of $40.7 million in 2023 frame the typical range for Current Assets.
  • The sharpest annual moves came in 2025 and 2026: Current Assets tumbled 34.92% in 2025, then surged 138.09% in 2026.
  • A 5-year view of Current Assets shows it stood at $43.1 million in 2022, then dropped by 4.39% to $41.2 million in 2023, then slipped by 23.98% to $31.3 million in 2024, then fell by 13.82% to $27.0 million in 2025, then surged by 106.85% to $55.8 million in 2026.
  • Business Quant data shows SLGL's Current Assets at $55.8 million in Q1 2026, $27.0 million in Q4 2025, and $31.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.31 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 521.86 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 10.37 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.25 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 3.59 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.63 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 11.73 Bn
9 Abivax 91.96 Bn 91.96 Bn - 600.85 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 55.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 55.79 Mn
Dec 31, 2025 26.97 Mn
Sep 30, 2025 31.65 Mn
Jun 30, 2025 36.26 Mn
Mar 31, 2025 23.43 Mn
Dec 31, 2024 31.30 Mn
Sep 30, 2024 37.95 Mn
Jun 30, 2024 38.28 Mn
Mar 31, 2024 36.01 Mn
Dec 31, 2023 41.17 Mn
Sep 30, 2023 45.47 Mn
Jun 30, 2023 51.59 Mn
Mar 31, 2023 40.68 Mn
Dec 31, 2022 43.06 Mn
Sep 30, 2022 47.56 Mn
Jun 30, 2022 48.48 Mn
Mar 31, 2022 46.72 Mn
Dec 31, 2021 57.11 Mn
Sep 30, 2021 48.15 Mn
Jun 30, 2021 41.39 Mn